In my opinion, HL the ~$3 Billion dollar market cap pharma would be the main stumbling block in a BP acquisition.
Besides, as far as I can tell, Resverlogix has in no time ever spoken about searching for a BP buyout. They hired Eversana for commercializing "Apabetalone" in-house as I understand it.
Koo